sk&f 83959 has been researched along with a 77636 in 1 studies
Studies (sk&f 83959) | Trials (sk&f 83959) | Recent Studies (post-2010) (sk&f 83959) | Studies (a 77636) | Trials (a 77636) | Recent Studies (post-2010) (a 77636) |
---|---|---|---|---|---|
94 | 0 | 46 | 55 | 0 | 17 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coe, J; Davoren, JE; Dlugolenski, K; Gray, D; Harris, AR; Helal, C; Kozak, R; LaChapelle, E; Liang, S; Liu, Y; Nason, D; O'Connor, R; Orozco, CC; Rai, BK; Salafia, M; Samas, B; Xu, W | 1 |
1 other study(ies) available for sk&f 83959 and a 77636
Article | Year |
---|---|
Discovery and Lead Optimization of Atropisomer D1 Agonists with Reduced Desensitization.
Topics: Animals; Biological Availability; CHO Cells; Cricetulus; Cyclic AMP; Dogs; Dopamine Agonists; Dose-Response Relationship, Drug; Half-Life; HEK293 Cells; High-Throughput Screening Assays; Humans; Madin Darby Canine Kidney Cells; Male; Mice, Inbred Strains; Neurons; Rats; Receptors, Dopamine D1; Stereoisomerism; Structure-Activity Relationship | 2018 |